Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Clinical Trials, Phase I Medicine & Life Sciences
Mutation Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2018

2 Citations

Activation of 4-1BB on liver myeloid cells triggers hepatitis via an interleukin-27–dependent pathway

Bartkowiak, T., Jaiswal, A. R., Ager, C. R., Chin, R., Chen, C. H., Budhani, P., Ai, M., Reilley, M. J., Sebastian, M. M., Hong, D. S. & Curran, M., Mar 1 2018, In : Clinical Cancer Research. 24, 5, p. 1138-1151 14 p.

Research output: Contribution to journalArticle

Myeloid Cells

Advances on the BRAF front in colorectal cancer

Janku, F., Apr 1 2018, In : Cancer discovery. 8, 4, p. 389-391 3 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Colorectal Neoplasms

A first-in-human phase 1 study of LY3023414, an Oral PI3K/mTOR dual inhibitor, in patients with advanced cancer

Bendell, J. C., Varghese, A. M., Hyman, D. M., Bauer, T. M., Pant, S., Callies, S., Lin, J., Martinez, R., Wickremsinhe, E., Fink, A., Wacheck, V. & Moore, K. N., Jul 15 2018, In : Clinical Cancer Research. 24, 14, p. 3253-3262 10 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Drug Interactions